Meropenem Injection, Powder, For Solution
Product Images NDC 44567-145

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 44567-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure diagram of Meropenem showing its molecular arrangement including the beta-lactam ring, sulfur atom, and various functional groups, with a 3H2O hydration notation.*

FDA Label Image

500 mg Meropenem Vial Label (Image 02)

Label for Meropenem for Injection, USP 500 mg per vial, injection powder for solution by WG Critical Care, LLC. The label states it is for intravenous use only, single-dose vial, prescription only, and sterile contents. Storage instructions and lot number/expiration date fields are visible. The label includes barcodes and manufacturer information.*

FDA Label Image

1 Gram Meropenem Vial Label (Image 03)

Meropenem 1 gram per vial injection label showing it is an intravenous, sterile single-dose vial. The label indicates the product contains meropenem equivalent to 1 gram, manufactured by WG Critical Care, LLC, and made in Switzerland. Directions for use and storage conditions are included, along with barcode and lot number details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.